The invention consists of an early diagnosis method for colorectal cancer (CRC) from blood samples.
A new drug to delay the spread of ovarian cancer, which was developed from UCL research, has been licensed for use in the UK.
The unique forum convening public and private sector leaders for networking, intelligence and debates on research and innovation.
These updates are republished press releases and communications from members of the Science|Business Network
Receive our news bulletin each Tuesday & Thursday and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
Sign up for the Bulletin
Sign up for The Widening